Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ADP-ribosylation factor guanine nucleotide exchange factors (ARF-GEFs) are a family of proteins that catalyze the exchange of GDP for GTP on ADP-ribosylation factors (ARFs), which are small GTP-binding proteins involved in membrane trafficking, vesicle formation, and cytoskeletal dynamics. ARF-GEFs play a central role in regulating the activity of ARFs by promoting their active, GTP-bound state. They contain a conserved Sec7 domain responsible for nucleotide exchange activity and are divided into subfamilies like Gea/GBF/GNOM, Sec7/BIG, Cytohesin/ARNO, and EFA6, each with distinct localization and function. Their activity is often sensitive to brefeldin A (BFA). Dysregulation has been linked to diseases involving secretion disorders or neurodegeneration.
Catalyzes GDP-to-GTP exchange on ARFs, activating them for downstream signaling in vesicle formation and protein trafficking.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ADP-ribosylation factor guanine nucleotide exchange factors (ARF-GEFs).